Fundraising Fox
Capacity Bio
Palo Alto, US · Founded 2021 · Delaware corporation · 7 employees on LinkedIn · 5 known investors
Find your way into Capacity Bio
Sign up to see every warm intro you have to Capacity Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Capacity Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Capacity Bio is a biotechnology company developing mitophagy modulators — small molecules, peptides, and nanoparticles that target mitochondrial biology to identify and clear dysfunctional mitochondria. Its pipeline includes a first-in-class mitophagy agonist intended for therapeutic use in aging- and disease-related conditions.
Founders & leadership
Board
Investors · 5
How we know: Remiges Ventures, Inc.'s portfolio page · the company's own site · a partner's Signal profile · press coverage · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the company's own site · a partner's Signal profile · funding news · press coverage · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the company's own site · press coverage · Not right? Tell us
How we know: AN Venture Partners's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$19.2M disclosed across 1 round · 2022
▶$19.2MraisedJan 2023 · 13 investors · PharmaceuticalsRule 506(b)
- Kenneth HorneExecutive Officer, Director
- Taro InabaDirector
- Dylan MorrisDirector
- Amy WangExecutive Officer, Director
- Cristina GhenoiuDirector
- Offering amount
- $35.3M
- Amount sold
- $19.2M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Capacity Bio.
In the news
Frequently asked questions
- What does Capacity Bio do?
- Capacity Bio is a biotechnology company developing mitophagy modulators — small molecules, peptides, and nanoparticles that target mitochondrial biology to identify and clear dysfunctional mitochondria. Its pipeline includes a first-in-class mitophagy agonist intended for therapeutic use in aging- and disease-related conditions.
- Who are Capacity Bio's investors?
- Capacity Bio's investors include Remiges Ventures, Inc., Insight Partners, RA Capital, AN Venture Partners, RDiscovery.
- How much funding has Capacity Bio raised?
- Capacity Bio has disclosed $19.2M raised across 1 round.
- Where is Capacity Bio headquartered?
- Capacity Bio is headquartered in Palo Alto, US.